Relating Experienced To Recalled breathlessness Observational (RETRO) study: a prospective study using a mobile phone application

Jacob Sandberg, Robert Lansing, Peter Anderberg, David Currow, Josefin Sundh, Zainab Ahmadi, Sebastian Palmqvist, Magnus Ekström, Jacob Sandberg, Robert Lansing, Peter Anderberg, David Currow, Josefin Sundh, Zainab Ahmadi, Sebastian Palmqvist, Magnus Ekström

Abstract

Background: Breathlessness, the subjective sensation of breathing discomfort, is common and appears in the daily life of people with cardiorespiratory diseases. Physicians often rely on patient's history based on symptom recall. The relation between recalled and experienced breathlessness is still poorly understood. This paper presents the protocol for a study primarily aimed at evaluating the relationship between experienced breathlessness and (1) recalled breathlessness and (2) predicted future breathlessness.

Methods: A mobile phone application will be used to collect data during daily life. Medically stable participants, ≥18 years of age with mean daily breathlessness of Numerical Rating Scale (NRS) 3/10 and able to use a mobile phone with internet will rate their breathlessness intensity on a 0-10 NRS prompted the user several times daily for 1 week. Participants will recall their breathlessness each day and week. Multivariable random effects regression models will be used for statistical analyses.

Results: Results of the study will be submitted for publication in peer-reviewed journals and presented at relevant conferences.

Discussion: This protocol describes a study aimed at investigating previously unknown areas of the experience and recall of breathlessness using a new method of data collection.

Registration details: Prospectively registered with ClinicalTrials.gov (Nr: NCT03468205).

Ethics and dissemination: The study has received ethical approval from the Regional Ethical Review Board Lund (DNr 2017/149). After a general study information including that participation is entirely voluntary, participants will answer the eligibility criteria and be asked to consent to participate before entering the study questions. Written informed consent to participate will be obtained for participants in the clinical sub-cohort. Participation can be discontinued at the discretion of the participant in which case no further data will be collected.

Keywords: app; breathlessness; cohort study; dyspnoea; mobile phone application; recall.

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
Overview of the timing of planned assessments, starting with eligibility, consent and baseline assessments then continuing with several daily prompts asking on intensity of breathlessness as well as morning, evening and weekly assessments including daily recall and daily predictions as well as a weekly recall.

References

    1. Grønseth R, Vollmer WM, Hardie JA, et al. . Predictors of dyspnoea prevalence: results from the BOLD study. Eur Respir J 2014;43:1610–20. 10.1183/09031936.00036813
    1. Lopez Varela MV, Montes de Oca M, Halbert RJ, et al. . Sex-related differences in COPD in five Latin American cities: the PLATINO study. Eur Respir J 2010;36:1034–41. 10.1183/09031936.00165409
    1. Bowden JA, To THM, Abernethy AP, et al. . Predictors of chronic breathlessness: a large population study. BMC Public Health 2011;11:33 10.1186/1471-2458-11-33
    1. Lansing RW, Gracely RH, Banzett RB. The multiple dimensions of dyspnea: review and hypotheses. Respir Physiol Neurobiol 2009;167:53–60. 10.1016/j.resp.2008.07.012
    1. Stevens JP, Dechen T, Schwartzstein R, et al. . Prevalence of dyspnea among hospitalized patients at the time of admission. J Pain Symptom Manage 2018;56:15–22. 10.1016/j.jpainsymman.2018.02.013
    1. Banzett RB, O'Donnell CR, Guilfoyle TE, et al. . Multidimensional dyspnea profile: an instrument for clinical and laboratory research. Eur Respir J 2015;45:1681–91. 10.1183/09031936.00038914
    1. Williams M, Garrard A, Cafarella P, et al. . Quality of recalled dyspnoea is different from exercise-induced dyspnoea: an experimental study. Aust J Physiother 2009;55:177–83. 10.1016/S0004-9514(09)70078-9
    1. Walentynowicz M, Bogaerts K, Van Diest I, et al. . Was it so bad? The role of retrospective memory in symptom reporting. Health Psychol 2015;34:1166–74. 10.1037/hea0000222
    1. Miravitlles M, Ferrer J, Baró E, et al. . Differences between physician and patient in the perception of symptoms and their severity in COPD. Respir Med 2013;107:1977–85. 10.1016/j.rmed.2013.06.019
    1. Lari SM, Attaran D, Tohidi M. Improving communication between the physician and the COPD patient: an evaluation of the utility of the COPD assessment test in primary care. Patient Relat Outcome Meas 2014;5:145–52. 10.2147/PROM.S54484
    1. Bourbeau J, Bartlett SJ. Patient adherence in COPD. Thorax 2008;63:831–8. 10.1136/thx.2007.086041
    1. Fredrickson BL. Extracting meaning from past affective experiences: the importance of peaks, ends, and specific emotions. Cogn Emot 2000;14:577–606. 10.1080/026999300402808
    1. Redelmeier DA, Katz J, Kahneman D. Memories of colonoscopy: a randomized trial. Pain 2003;104:187–94. 10.1016/S0304-3959(03)00003-4
    1. Walentynowicz M, Bogaerts K, Stans L, et al. . Retrospective memory for symptoms in patients with medically unexplained symptoms. J Psychosom Res 2018;105:37–44. 10.1016/j.jpsychores.2017.12.006
    1. Meek PM, Lareau SC, Anderson D. Memory for symptoms in COPD patients: how accurate are their reports? Eur Respir J 2001;18:474–81. 10.1183/09031936.01.00083501
    1. Kroenke K, Spitzer RL, Williams JB. The PHQ-15: validity of a new measure for evaluating the severity of somatic symptoms. Psychosom Med 2002;64:258–66. 10.1097/00006842-200203000-00008
    1. American Psychiatric Association Diagnostic and statistical manual of mental disorders. 5th ed Washington DC, 2013.
    1. Borland E, Nägga K, Nilsson PM, et al. . The Montreal Cognitive assessment: normative data from a large Swedish population-based cohort. J Alzheimers Dis 2017;59:893–901. 10.3233/JAD-170203
    1. Nasreddine ZS, Phillips NA, Bédirian V, et al. . The Montreal Cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 2005;53:695–9. 10.1111/j.1532-5415.2005.53221.x
    1. Crişan AF, Oancea C, Timar B, et al. . Cognitive impairment in chronic obstructive pulmonary disease. PLoS One 2014;9:e102468 10.1371/journal.pone.0102468
    1. Alagiakrishnan K, Mah D, Dyck JR, et al. . Comparison of two commonly used clinical cognitive screening tests to diagnose mild cognitive impairment in heart failure with the Golden Standard European Consortium criteria. Int J Cardiol 2017;228:558–62. 10.1016/j.ijcard.2016.11.193
    1. Dag E, Bulcun E, Turkel Y, et al. . Factors influencing cognitive function in subjects with COPD. Respir Care 2016;61:1044–50. 10.4187/respcare.04403
    1. Johnson MJ, Bland JM, Oxberry SG, et al. . Clinically important differences in the intensity of chronic refractory breathlessness. J Pain Symptom Manage 2013;46:957–63. 10.1016/j.jpainsymman.2013.01.011
    1. Frändin K, Grimby G. Assessment of physical activity, fitness and performance in 76-year-olds. Scand J Med Sci Sports 1994;4:41–6. 10.1111/j.1600-0838.1994.tb00404.x
    1. Parshall MB, Schwartzstein RM, Adams L, et al. . An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea. Am J Respir Crit Care Med 2012;185:435–52. 10.1164/rccm.201111-2042ST
    1. Fletcher C. Discussion on the diagnosis of pulmonary emphysema. Proc R Soc Med 1952;45:576–86.
    1. Fletcher CM, Tinker CM. Chronic bronchitis. A further study of simple diagnostic methods in a working population. Br Med J 1961;1:1491–8.
    1. Mahler DA, Wells CK. Evaluation of clinical methods for rating dyspnea. Chest 1988;93:580–6. 10.1378/chest.93.3.580
    1. Ekström M, Sundh J. Swedish translation and linguistic validation of the multidimensional dyspnoea profile. Eur Clin Respir J 2016;3:32665 10.3402/ecrj.v3.32665

Source: PubMed

3
Abonnieren